NewGenIvf Group Limited (NIVF)

NewGenIvf Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	4.73	5.43	5.14	5.94	4.12
Revenue Growth (YoY)	-13.01%	5.79%	-13.59%	44.34%	-
Cost of Revenue	3.77	3.61	3.45	4.41	3.09
Gross Profit	0.96	1.83	1.68	1.54	1.02
Selling, General & Admin	11.68	2.99	1.64	1.14	0.83
Operating Expenses	11.68	2.99	1.64	1.14	0.83
Operating Income	-10.73	-1.16	0.04	0.4	0.2
Interest Expense	-0.62	-0.78	-0.05	-0.08	-0.09
Interest & Investment Income	0	0.01	0	0	0
Other Non Operating Income (Expenses)	0.16	0.97	0.11	0.02	0.05
EBT Excluding Unusual Items	-11.18	-0.96	0.11	0.34	0.16
Gain (Loss) on Sale of Investments	-0.7	-	-	-	-
Gain (Loss) on Sale of Assets	-0.05	-	-	-	-
Other Unusual Items	21.65	-	-	-	-
Pretax Income	9.73	-0.96	0.11	0.34	0.16
Income Tax Expense	-	-0.49	-	0.21	0.29
Earnings From Continuing Operations	9.73	-0.47	0.11	0.14	-0.14
Minority Interest in Earnings	0.15	-0.05	0.02	0.32	0.14
Net Income	9.88	-0.52	0.13	0.46	-0
Net Income to Common	9.88	-0.52	0.13	0.46	-0
Net Income Growth	-	-	-71.61%	-	-
Shares Outstanding (Basic)	0	-	-	-	-
Shares Outstanding (Diluted)	3	-	-	-	-
EPS (Basic)	214.73	-	-	-	-
EPS (Diluted)	3.04	-	-	-	-
Free Cash Flow	-11.06	-8.32	-1.84	1.62	1.42
Free Cash Flow Per Share	-3.40	-	-	-	-
Gross Margin	20.22%	33.62%	32.74%	25.87%	24.88%
Operating Margin	-226.95%	-21.36%	0.82%	6.71%	4.83%
Profit Margin	209.03%	-9.66%	2.54%	7.72%	-0.01%
Free Cash Flow Margin	-234.03%	-153.08%	-35.75%	27.19%	34.39%
EBITDA	-10.54	-1.14	0.07	0.5	0.37
EBITDA Margin	-222.97%	-21.00%	1.43%	8.40%	8.88%
D&A For EBITDA	0.19	0.02	0.03	0.1	0.17
EBIT	-10.73	-1.16	0.04	0.4	0.2
EBIT Margin	-226.95%	-21.36%	0.82%	6.71%	4.83%
Effective Tax Rate	-	-	-	60.51%	188.70%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q